Physician

Benson Chin, MD

According to 2025 Medicare claims, Benson Chin, MD (NPI: 1134218266) practices family practice in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. Chin uses personal NPI as billing NPI and primary practice location at 95993-2667. Chin is affiliated with the Vivant Health ACO (ACO ID: A5068), participating under the MSSP model.

Chin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 279 traditional Medicare patients, billed 12,000 HCPCS/CPT codes, and received $285,217 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,111 prescription claims across 284 beneficiaries totaling $556,425 in drug costs, led by Repatha Sureclick (Evolocumab). DME data shows 51 claims. Open Payments data shows 91 records totaling $1,716. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $160,270 to $285,217. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $27,974 to $11,807.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	303	3,563	$160,270
2016	280	3,354	$137,795
2017	289	3,915	$162,377
2018	322	4,453	$179,110
2019	320	5,172	$198,190
2020	305	5,572	$219,513
2021	339	6,797	$273,749
2022	302	8,574	$226,467
2023	309	8,015	$252,904
2024	279	12,000	$285,217

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	208	4,204	$522,396
2016	219	3,929	$479,151
2017	235	3,911	$415,571
2018	214	3,690	$448,958
2019	225	3,674	$461,934
2020	230	3,862	$486,106
2021	275	3,635	$546,613
2022	289	3,764	$603,285
2023	273	4,030	$660,664
2024	284	4,111	$556,425

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	66	454	$25,543
2016	51	414	$16,435
2017	38	357	$9,330
2018	45	315	$8,144
2019	38	197	$3,962
2020	31	203	$12,955
2021	28	169	$11,480
2022	18	183	$11,496
2023	15	102	$4,975
2024	14	51	$7,600

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	194	876	$88
90662	Influenza vaccine split virus, preservative free	83	83	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	180	576	$68
G0008	Administration of influenza virus vaccine	93	93	$33
96372	Injection of drug or substance under skin or into muscle	79	489	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Repatha Sureclick	Evolocumab	60	2,408	$45,511
Evenity (2 Syringes)	Romosozumab-Aqqg	19	552	$45,331
Farxiga	Dapagliflozin Propanediol	27	1,890	$33,859
Prolia	Denosumab	18	3,150	$30,464
Ozempic	Semaglutide	29	1,120	$29,075

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	27	$7,277
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	14	24	$323

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	91	$1,716	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Family practice providers in the Yuba City, CA market
Providers within practice ZIP code 95993-2667
Providers whose plurality patient county is Sutter, CA
Providers in California affiliated with Vivant Health ACO (MSSP)

FAQ

What Medicare data is available for Benson Chin, MD?

Tedicare shows public-source Medicare data for Benson Chin, MD (NPI 1134218266), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benson Chin, MD have ACO affiliation data?

Benson Chin, MD is shown with ACO affiliation data for Vivant Health ACO (MSSP, ACO ID A5068).

What billing organization is linked to Benson Chin, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Benson Chin, MD have Open Payments data?

Benson Chin, MD has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.